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Results: Figure 1a shows the cube propagation in the coronal 
direction and DVF of the inserts. Mean S-I distance are 
0.16±0.14cm for cube and 0.27±0.12cm for sphere. DVF have 
a mean magnitude scale of 0.00-1.11cm for the 4DCT. The 
mean transition has same dimension, according to the space 
covered by the objects during phases bin. The motion 
direction is obtained by reverse mode, otherwise uncorrected 
track is provided by the DVF module. Graph (Figure1b) shows 
the displacement of 2 ROIs in S-I directions per phases. A 
strong correlation (R2=0.95) with position, time and direction 
of the inserts (cube and sphere) is obtained (Figure 1c). 
 
Conclusions: DIR algorithms and DVF can be used to calculate 
motion object. A strong correlation with ROI mapping and 
spatial-time variable can obtained by 4DCT and hybrid 
deformable grid. Using DVF we can evaluate, adequately, the 
motion direction and distance between points. ROI Center of 
Mass is not reliable with motion. An anthropomorphic 
phantom, with 8 ribs, 2 tumors (Figure1d) is under 
developing, using LEGO® Mindstorms, to evaluate accuracy 
and criticalities in lung district of DIR, DVF and to 
understanding uncertainties on dose mapping during 
radiation, using TLD. 
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Purpose/Objective: IMRT is an established treatment option 
for patients with prostate cancer, as it allows the delivery of 
highly conformal doses to the target whilst lowering doses to 
OARs. In many centres, including ours, the provision of static 
field IMRT has been supplanted by VMAT which offers faster 
treatment times and greater monitor unit efficiency. The 
results of published dosimetric comparisons between IMRT 
and VMAT for prostate cancer have varied, typically with 
small sample sizes. Here we present a retrospective 
dosimetric audit of clinical IMRT and VMAT treatment plans 
for prostate cancer with a large sample size (N = 1344). 
Materials and Methods: Our standard prostate treatment is a 
three dose level integrated simultaneous-boost technique 
based on the CHHiP trial, with a prescription dose of 60Gy in 
20 fractions, delivery of which has moved from five-field 
step-and-shoot IMRT to predominantly single arc VMAT using 
Elekta linear accelerators. Planning is performed using the 
Philips Pinnacle TPS. 
Automatically populated dosimetric summary forms 
(AutoForms) are routinely generated at our centre for the 
purposes of optimisation and reporting. Prostate AutoForms 
were collected and cross-referenced with treatment planning 
system PDF reports to determine which patients were treated 
with IMRT or VMAT. Patients with artificial hip replacements 
were excluded as we do not treat these patients with VMAT. 
All data collection was fully automated. Target, rectum and 
bladder dosimetric statistics were compared using histograms 
and Mann-Whitney U tests, with a significance level of 0.01. 
It should be noted that our standard VMAT inverse 
optimisation class solution is slightly different to the IMRT 
version. However, all plans have been individually optimised 
by suitably trained individuals. 
Results: The volume of rectum receiving 41% of the 
prescription dose or greater, V41%, and V88% were 
significantly lower for VMAT than IMRT. However, V68% and 
V95% were significantly higher. Bladder dose statistics (V68%, 
V81% and V100%) were lower for VMAT but the differences 
were not significant. 
The percentage of the prescription dose covering 99% of each 
target volume, D99%, was significantly higher for VMAT than 
for IMRT. Sharp cut-offs at tolerance values were much more 
pronounced in the histograms for IMRT than for VMAT, 
supporting anecdotal evidence that coverage tolerances are 
more easily achieved using VMAT. Heterogeneity, defined as 
the difference between the maximum and minimum 
percentage dose to 1cc of the target volume, was 
significantly lower for VMAT than IMRT. 
Conclusions: We have performed a large dosimetric audit, 
comparing IMRT and VMAT for prostate cancer. Bladder dose 
statistics are not significantly different. Some rectum dose 
statistics are significantly greater for VMAT and others for 
IMRT. However, VMAT shows a clear advantage over IMRT in 
coverage statistics. Most strikingly of all, the dose to the 
target volume was much more homogeneous for VMAT than 
for IMRT. 
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Purpose/Objective: Beam Output variations have been 
associated with suboptimal patient’s outcome. As such, Beam 
Output Auditing (BOA) is an important aspect of the quality 
assurance (RTQA) program for all members of the Global 
Harmonisation Group (GHG). This study details the BOA 
results stemming from one of the GHG members participating 
actively in clinical trials and assesses factors that could be 
associated with suboptimal beam outputs within its network. 
Materials and Methods: A retrospective review of all BOA 
reports from 2005 onwards, available in the RTQA database, 
was conducted, based on the following parameters: center, 
country, date of audit, beam energies and treatment 
machines audited, auditing organisation, percentage of 
agreement between dose stated by the center and measured 
dose in reference conditions and ratio of measured dose over 
stated dose.  
Results: Four-hundred and sixty-one BOA-reports, stemming 
from February 2005 until December 2013, were assessed. In 
total, the results of 1790 photon beams and 1366 electron 
beams, delivered by 755 different treatment machines, were 
analyzed. On average 4 beams (range: 1-65) and 2 treatment 
units (range: 1-17) were audited during a BOA process. The 
majority of beams (91.1%) were within the optimal limit of < 
3%. Only 13 beams (0.4%; n=9 electrons; n=4 photons), were 
out of the range of acceptance of < 5% and 8.5% were within 
the non-optimal range (3-5%) of acceptance. No association 
was observed between the size of the center and the 
compliance of the BOA cutoff tolerance limit.  
 
 
Figure: European distribution of institutions providing BOA-
reports collected and stored by the GHG member. The ‘pie-
diagrams’ represent the subdivision between the different 
levels of acceptance [green: ≤3%; yellow: >3% and ≤ 5%; red: 
>5%]  
 
Conclusions: Our analysis shows that the majority (66.9%) of 
centers present beam output variations within the 3% 
tolerance cutoff and only 0.4% of all beam results were found 
discrepant in respect to a ± 5% level. Although these results 
are promising, a further gradually amelioration should be 
pursued together with the global harmonizing of the 
guidelines for beam output audits as the optimal number of 
beams to be audited and the optimal BOA acceptance criteria 
are not agreed upon yet among clinical trial organizing 
groups. 
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Purpose/Objective: Every day a large amount of data is 
produced within a radiotherapy department, although this 
data is available in one form or other within the centralised 
systems, it is often not in the form which is of interest to the 
user. Additionally the appropriate programs (clients) must be 
installed and maintained on all workstations. Moreover, few 
employees record or alter data, but merely want to retrieve 
data. Thus the idea was conceived, to present the user with 
all relevant information in a simple and effective manner. 
Ultimately the aim is to optimize clinical procedures, 
enhance transparency and improve revenue. 
Materials and Methods: In our working group many internal 
procedures were examined, to find out whether relevant 
information suitable for our purposes lay therein. After the 
results were collated it was necessary to select an effective 
software platform. After a more detailed analysis of all data 
it became clear that the implementation of Web services was 
appropriate. It was fortunate that in our institute several 
such web-based information services had already been 
developed over the last few years with which we gained 
experienced. Only for a few applications did we have to use 
MS-Windows conform software tools in order to have direct 
access to data and programs of the operating system; by and 
large this consisted of communication processes, which were 
not directly accessed by the user, rather than background 
applications that run on servers.  
Results: By employing web services we reached high 
effectiveness, transparency and efficient information 
processing for the user. Furthermore, we achieved an almost 
maintenance-free and low support system. In addition due to 
wide spread use of web-based technology the training effort 
was effectively nil since practically every user can master the 
use of a web-browser. Moreover, we strived for high 
acceptance amongst staff members. The aim of the project 
presenting the user with web-based information from the 
departmental system MOSAIQ TM, physician letter system 
MEDATEC and the central finding server MiraPlus (laboratory, 
pathology and radiology) could be implemented without 
restrictions. 
Conclusions: Due to wide spread use of web-based 
technology the training effort was effectively nil since 
practically every user can master the use of a web-browser. 
Moreover, we strived for high acceptance amongst staff 
members and have improved our effectiveness a considerable 
time saving. 
The many MOSAIQ-specific parts of the system can be readily 
used by departments which use MOSAIQ as the departmental 
system. 
   
 
